Cyrla Hababou

Cyrla Hababou is a seasoned medical professional with extensive experience in the pharmaceutical industry, currently serving as Directeur médical at Alnylam Pharmaceuticals since February 2017 and at NPS Pharmaceuticals since August 2014. Previous roles include Directeur des affaires publiques and Directeur des affaires scientifiques at Celgene, and Médecin produit en oncologie at Amgen. Early in the career, Cyrla held positions at Janssen-Ortho, Laboratoires Lilly, Laboratoire Diamant, and GSK, with a focus on medical affairs and clinical research. Educational credentials include a Doctor of Medicine (MD) from Université Paris-Est Créteil, an Internat de paris en biologie médicale, and a specialized Master's in medical management from Ecole supérieur de commerce de Paris.